Sec. Integrative Physiology
Volume 3 - 2012 | https://doi.org/10.3389/fphys.2012.00318
Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life
- European Institute of Oncology, Milan, Italy
Over the last several years, new evidence has kept pouring in about the remarkable effect of caloric restriction (CR) on the conspicuous bedfellows- aging and cancer. Through the use of various animal models, it is now well established that by reducing calorie intake one can not only increase life span but, also, lower the risk of various age related diseases such as cancer. Cancer cells are believed to be more dependent on glycolysis for their energy requirements than normal cells and, therefore, can be easily targeted by alteration in the energy-metabolic pathways, a hallmark of CR. Apart from inhibiting the growth of transplantable tumors, CR has been also shown to inhibit the development of spontaneous, radiation, and chemically induced tumors. The question regarding the potentiality of the anti-tumor effect of CR in humans has been in part answered by the resistance of a cohort of women, who had suffered from anorexia in their early life, to breast cancer. However, human research on the beneficial effect of CR is still at an early stage and needs further validation. Though the complete mechanism of the anti-tumor effect of CR is far from clear, the plausible involvement of nutrient sensing pathways or IGF-1 pathways proposed for its anti-aging action cannot be overruled. In fact, cancer cell lines, mutant for proteins involved in IGF-1 pathways, failed to respond to CR. In addition, CR decreases the levels of many growth factors, anabolic hormones, inflammatory cytokines, and oxidative markers that are deregulated in several cancers. In this review, we discuss the anti-tumor effect of CR, describing experiments done in vitro in tumor models and in vivo in mouse models in which the tumor was induced by means of radiation or chemical exposure, expressing oncogenes or deleting tumor suppression genes. We also discuss the proposed mechanisms of CR anti-tumor action. Lastly, we argue the necessity of gene expression studies in cancerous versus normal cells upon CR.
Growing awareness that diet and environmental factors have a profound effect in the initiation, promotion, and progression of cancer argues that cancer is a preventable disease. In fact, alteration in the eating habit from traditional to westernized diets appears to correlate with the increased risk of many common cancers in both developed and developing countries (Baade et al., 2009; Kolonel et al., 2004). For example, prostate cancer, which was previously prevalent only in developed countries, showed an increased incidence rate in less developed and developing countries, due to westernization of food habits (Baade et al., 2009). Further, studies of ethnic and migrant groups in Hawaii showed adaptation of Japanese immigrant cancer risk incidences to those of native Hawaiian people (Kolonel et al., 2004). These observations reinforce the belief that environment and diet have an impact on cancer development. The increased risk of breast cancer in Japanese women who migrated to US also supports the influence of environment and diet on the pathogenesis of cancer (Probst-Hensch et al., 2000). In addition, observational studies showing a decreased risk of cancer in a population with a dietary habit enriched for plant food, and limited consumption of animal fat and dairy products, also point toward the importance of diet in cancer (Kushi et al., 2006). Obesity due to over eating has been shown to be associated with increased risk of colon, breast (in post-menopausal women), endometrium, kidney, esophagus, pancreas, prostate, gallbladder, and liver cancer (Calle and Kaaks, 2004). It is believed that increased food consumption can influence the expression of genes involved in important cellular functions, such as DNA repair, cell proliferation and differentiation, and apoptosis, by altering the levels of metabolic hormones and growth factors, and can lead to accumulation of damage and mutations and ultimately malignant transformation (Hursting et al., 1999; Calle and Kaaks, 2004). Therefore, it can be assumed that by controlling our diet we might also control cancer risk. Caloric restriction (CR), which can be defined as “under nutrition without malnutrition,” has emerged as a robust method to decrease cancer incidence, besides increasing the life span of the individuals (Sell, 2003). CR has been shown to reduce the levels of many cancer-causing agents like anabolic hormones, growth factors, and reactive oxygen species (ROS) in animal models. Unfortunately, the exact metabolic adaptation through which CR exhibits its anti-tumor effect is not completely understood. However, at least in part, the mechanism responsible for the anti-tumor effect of CR involves a similar metabolic adaptation as seen in the case of its anti-aging effect. The anti-proliferative and pro-apoptotic properties of CR, in addition to its ability to decrease oxidative stress and maintain genomic stability, could be responsible for its anti-tumor activity.
Here, we discuss the existing evidence regarding the anti-tumor activity of dietary/energy restriction and factors and pathways crucial for its effect. We also discuss the putative parallel mechanisms through which CR exerts both anti-aging and anti-tumor activities. An insight into how anti-aging effects may also lead to tumorigenesis is also provided. Finally, we discuss the potential of CR interventions at clinical level.
Caloric Restriction as a Promising Natural Approach to Overcome Cancer
Realization that both the environment and the diet of an individual can influence the occurrence of cancer has heightened the idea that cancer is a preventable disease. Epidemiological studies have also shown a correlation between weight of an individual and development of tumors suggesting that controlling the diet may contribute to cancer prevention (Tannenbaum, 1940, 1942; Collaborative Group on Epidemiological Studies of Ovarian Cancer, 2012). In fact, beside the recognized effects that restriction in calorie intake has on aging, increasing evidence also supports a role of CR in inhibiting tumor. The first ever observation on the anti-tumor activity of CR was made in the early 1900's. One of the very first experiments in mice and rats showed that lowering the weight by CR can lower the frequency of various types of spontaneous tumors and other inducible tumors (Mccay et al., 1939; Tannenbaum, 1940). More recently, experiments carried out in tumor susceptible C3H/He female mice showed that a change in diet to 70% of the ad-libitum diet could single-handedly suppress the spontaneously occurring mammary tumor, suggesting a new way of restricting tumor growth (Kharazi et al., 1994). The fact that CR is linked to a reduction of the levels of mouse mammary tumor virus (MMTV) RNA and incidences of spontaneous mammary tumor further reinforces this belief (Li et al., 1994). Furthermore, in an attempt to find out differences in tumor biology with age, Pili et al. found that young mice that were otherwise vulnerable to tumor growth and expansion as compared to old mice, when fed on a caloric restricted diet showed a decrease in the growth of transplantable tumors and decreased angiogenesis (Pili et al., 1994). In addition, CR has also been shown to be effective against chemically and radiation induced leukemia, and mammary and liver tumors (Beth et al., 1987; Ruggeri et al., 1989; Fu et al., 1994; Yoshida et al., 1997, 1999, 2006). The anti-tumor ability of CR was also observed in animal models of pancreatic, colon, breast, prostate, and lung tumor, proving it to be active against various kinds of cancer (Figure 1A) (Bunk et al., 1992; Roebuck et al., 1993; Mukherjee et al., 1999, 2002; Dirx et al., 2003a,b; Mai et al., 2003; Phoenix et al., 2010; Lashinger et al., 2011). The inhibitory effect of CR appears to depend on a caloric intake restriction ranging from 25% up to 60% of ad-libitum levels, combined with adequate intakes of essential nutrients. Interestingly, experiments in rats showed that by increasing the degree of CR intervention, the reduction in chemically-induced tumor incidence was intensified (Figure 1B) (Ruggeri et al., 1989; Kumar et al., 1990). Most importantly, a very recent study, using a mouse model of post-menopausal obesity, provided the evidence that CR can break the obesity-cancer progression link offering a new hope to women vulnerable to post-menopausal breast cancer (Nogueira et al., 2012). Several studies using mouse models of brain tumor showed CR to be effective not only in non-invasive tumors but also in the most aggressive and invasive forms of brain tumor, proving it to have anti-proliferative, anti-angiogenic, and anti-invasive properties (Mukherjee et al., 2002, 2004; Zhou et al., 2007; Shelton et al., 2010). Recently, CR has also been shown to be beneficial for mice lacking the tumor suppressor p53. In fact, mice lacking p53 develop lymphoma by six months of age and die very early; however, when put on a calorie restriction diet, these mice live longer due to decreased tumor incidence (Hursting et al., 1994, 1997). This is very interesting as p53 is known to be non-functional in almost all types of human cancer, either because of its own mutation or mutation in its regulator/s. This last observation again indicates that CR might constitute an effective intervention for a prolonged healthier life. So far, the only tumor types which failed to respond to calorie restricted diets are the tumors carrying a mutation in either PI3K or PTEN genes, thus leading to the constitutive activation of the PI3K pathway (Kalaany and Sabatini, 2009). Table 1 summarizes the amount of calorie restriction in percentage or kcal/day or kcal/week in the above mentioned studies.
Figure 1. Caloric Restriction (CR) and Cancer. (A) CR effectively inhibits various kinds of cancer in animal models. (B) Correlation between decrease in the incidence of tumor and severity of CR. (C) Demonstration of parallel and opposing effects of CR on cancer and aging. The ability of CR to decrease the levels of IGF-1 and ROS and inhibit the PI3K-AKT pathway can simultaneously protect cells from aging and cancer. However, CR ability to maintain telomere length and reduce the frequency of senescence can promote cancer but may be also beneficial in delaying aging.
Proposed Mechanisms for the Anti-Tumor Activity of Caloric Restriction
The mechanisms responsible for the observed effect of CR in aging, cancer and other chronic diseases are still under scrutiny. The initial studies indicated the involvement of similar mediators and pathways for both the anti-aging and anti-tumor activity of CR. Accumulation of cellular damage is assumed as one of the initiating events in aging and cancer. ROS, which are natural byproducts of cell normal metabolism and are capable of damaging macromolecular components of the cells, including proteins, lipids and DNA, are considered as the main culprit. In the cells, ROS are neutralized by the action of anti-oxidant enzymes to avoid oxidative damage. However, as the cells age, their capacity to neutralize ROS diminishes, leading to accumulation of macromolecular damage. Moreover, tumorigenesis is also fuelled by accumulation of cellular damage, partly by increased intrinsic ROS stress due to oncogene stimulation, increased metabolic activities, and mitochondrial malfunction (Pelicano et al., 2004). Thus, regulation of oxidative stress could be the mechanism in common between CR anti-tumor and anti-aging activities. In fact, 25–40% CR was shown to maintain the otherwise diminishing levels of anti-oxidant defense systems in aging rodents (Youngman et al., 1992). Further, 30% CR was shown to decrease nitric oxide production in p53 deficient mice and delay tumorigenesis (Hursting et al., 1994, 2001; Mei et al., 1998). The ability of CR to reduce oxidative stress was recently shown to be dependent on SIRT3, a deacetylase (Qiu et al., 2010) and mice deficient in SIRT3 were shown to be prone to both aging and cancer and failed to respond to CR (Kim et al., 2010).
Another highly studied common mediator for the anti-tumor and anti-aging activity of CR is IGF-1 (Insulin Growth Factor 1). The involvement of IGF-1 in aging is supported by the availability of nutrition studies in yeast, nematode, fruit fly and mouse (Gems and Partridge, 2001). Mutants of Drosophila that exhibited alteration of insulin/IGF-1 signaling pathways lived longer (Clancy et al., 2001; Tatar et al., 2001). Life span extension in C. elegans requires deregulation of Insulin/IGF-1 signaling (Lin et al., 2001). The importance of IGF-1 in life span extension is also observed in genetically modified mice defective for growth hormone (GH) or IGF-1 production (Flurkey et al., 2001). These mice live longer as compared to wild type mice. The production of IGF-1 by the liver was shown to be stimulated by GH (Isaksson et al., 1987). Many of the several biological roles of GH seem to depend on its interaction with the growth hormone receptor/binding protein (GHR/BP). Coschigano and colleagues reported that mice with disruption in GHR/BP, although showing high levels of circulating GH, had lower serum levels of IGF-1 in comparison to wild type, and lived longer (Coschigano et al., 2000). All these studies show the importance of the IGF-1 pathway in aging. CR was invariably shown to decrease the IGF-1 serum levels in animal studies (Weindruch and Walford, 1988; Ruggeri et al., 1989; Hursting et al., 1993; Berrigan et al., 2002). Interestingly, the injection of IGF-1 in the mice reversed the CR effect. Furthermore, the ability of CR to regulate IGF-1 levels and the Insulin/IGF-1 pathway could also be responsible for its anti-tumor effect as an elevated IGF-1 serum level is associated with an increased risk of breast, prostate, colon, and lung cancer in humans (Chan et al., 1998; Hankinson et al., 1998; Schaefer et al., 1998; Wolk et al., 1998; Ma et al., 1999; Yu et al., 1999). Involvement of IGF-1 in cancer is further supported by its ability to enhance the growth of a variety of cancer cell lines (Macaulay, 1992; LeRoith et al., 1995; Singh et al., 1996). The tumorigenic property of IGF-1 is thought to be due to its ability to regulate mitogenic and anti-apoptotic pathways (Resnicoff et al., 1995; Yu and Rohan, 2000). In fact, in a transplantable and spontaneous leukemia mouse model, CR has been shown to reduce serum IGF-1 level and decrease leukemia cell proliferation (Hursting et al., 1993). Interestingly, the anti-proliferative effect of CR on leukemia cells was annulled by restoration of serum IGF-1 concentration (Hursting et al., 1993). Similarly, in p53 deficient mice, restoration of IGF-1 levels reverses the beneficial effect of CR on p-cresidine induced carcinogenesis (Dunn et al., 1997). Hence, it can be assumed that, at least in part, CR modulation of IGF-1 mediates its anti-tumor and anti-aging effects.
Recently, the Forkhead box-O (FOXO) family of proteins has been shown to be required for the anti-tumor and anti-aging activity of CR (Greer et al., 2009; Yamaza et al., 2010). The FOXO family of transcription factors is a direct target of the PI3K-AKT pathway (Lin et al., 1997; Ogg et al., 1997). Activation of the PI3K-AKT pathway leads to the phosphorylation and inactivation of FOXO by AKT. However, its phosphorylation by AMPK enhances its transcriptional activity (Greer et al., 2009). FOXO transcription factors, by modulating specific targets genes (p21, p27, cyclin G2, BIM1, Bcl-6, FasL, GADD45, MnSOD, catalase), promote a variety of cellular responses such as cell cycle arrest, apoptosis, DNA repair and resistance to cellular stress (Greer and Brunet, 2005), hence representing an attractive tumor suppressor candidate. Interestingly, FOXO3 has been found to be deregulated in breast cancer (Hu et al., 2004). Moreover, expression of an active form of FOXO suppresses tumor in transplanted nude mice (Hu et al., 2004; Yang et al., 2005). Further, expression of a constitutive active form of FOXO has been shown to inhibit tumorigenesis in PTEN-null cells (Ramaswamy et al., 2002). An indication of the involvement of FOXO in longevity comes from a study in mutant worms where the increased longevity, due to mutations in the insulin receptor and PI3K, was reversed by an additional mutation in the FOXO ortholog Daf-16 (Lin et al., 1997; Ogg et al., 1997; Kenyon, 2005). Studies in worm have shown that CR ability to extend life span is dependent on AMPK, which partly acts via FOXO (Greer et al., 2007). The inability of CR to extend life span in the FOXO (daf-16) mutant strongly indicates FOXO as a mediator of its anti-aging activity (Greer et al., 2007). The requirement of FOXO in the antineoplastic effect of CR has been shown using FOXO1 knockout heterozygous mice. In comparison to wild type mice, these mice failed to recapitulate the beneficial effect of CR on tumor development. Wild type mice on CR diet showed lower incidence of tumor and tumor related deaths as compared to FOXO1 knockout heterozygous mice (Yamaza et al., 2010), thus suggesting FOXO as a mediator of CR anti-tumor effects as well.
The Divergent Mechanism of Caloric Restriction in Aging and Cancer
The assumption that the anti-tumor ability of CR is a parallel effect of its anti-aging activity and vice-versa is a debatable issue. The regulation of GHs, oxidative stress, DNA damage, and metabolic pathways by CR could simultaneously result in its anti-tumor and anti-aging activities (Figure 1C). Recent studies have shown that CR reduces the frequency of senescent cells in the liver and small intestine of mice (Wang et al., 2010). CR effect on cellular senescence, a cause of aging, could be crucial to its anti-aging activity (Goldstein, 1990; Wang et al., 2010). However, this property of CR could also be beneficial to tumor cells where induction of senescence is an effective tumor suppressor mechanism (Lleonart et al., 2009). Further, CR has been shown to maintain telomere length, another process important for tumorigenesis (Feldser and Greider, 2007; Wang et al., 2010). Experiment by Oliverras-Ferraros showed that cancer cell lines can be maintained in culture for several months in the presence of CR mimetics (CRM) (Oliveras-Ferraros et al., 2010). Gene expression analysis suggests the retrogression from a more differentiated state to a stem like primitive step in the presence of CRM (Oliveras-Ferraros et al., 2010). While this finding promises potential applications in the replacement of adult aging tissues, it is, at the same time, a matter of concern as regards tumor biology. Another interesting observation is the regulation of SIRT1 by p53 in response to CR. It seems that the induction of SIRT1 under the condition of nutrient deprivation requires occupancy of its promoter by p53. Any mutation that affects the binding of p53 to the SIRT1 promoter region affects SIRT1 up-regulation in response to CR. Therefore, it appears that the SIRT1-mediated beneficial effect of CR requires an active p53 and its binding on SIRT1 (Naqvi et al., 2010). However, the ability of CR to exert its ant-tumor effect in the absence of p53, further points towards the singular regulation of aging and cancer by CR (Hursting et al., 1997). In this context, it is essential to understand how CR carries out both anti-tumor and anti-aging activities, and whether its effects occurs through the same mechanism but with parallel and opposing results on cancer and aging. Further investigations are required (Figure 1C).
Other Possible Mechanisms for the Anti-Tumor Activity of Caloric Restriction
While one of the mechanisms responsible for CR-mediated beneficial effects on cancer has been shown to involve the same metabolic adaptation implicated in its anti-aging effects, the role of other specific mediators and pathways cannot be ruled out. One possibility could be the regulation of oncogenes and tumor suppressor genes by CR. For example, gene expression analysis of liver from mice fed on caloric restricted diet revealed significant changes in the genes involved in p53 dependent cell cycle and apoptosis (Estep et al., 2009). One of the most highly up regulated genes in the liver of CR fed mice was DNA-damage inducible transcript 4 (Ddit4), a p53 controlled negative regulator of the m-TOR pathway (Wei et al., 2006; Estep et al., 2009). Ddit4 is a known tumor suppressor whose expression has shown to be down regulated in a subset of human cancers (Deyoung et al., 2008). CR mediated up-regulation of the Ddit4 transcript could be one of many ways by which CR exerts its anti-tumor effect. Analysis of pancreatic acinar cells from CR-fed Brown Norway Rat revealed reduced expression of the c-Ha-Ras oncogene and reduced mutations in the p53 gene (Hass et al., 1993). Further, study in mouse mammary tumor/v-Ha-ras transgenic mice showed that a restricted diet decreases the tumor incidence in these mice, may be through CR mediated increased levels of the tumor suppressor p53 and scavenging enzymes and decreased levels of c-erbB2 and v-Ha-ras RNA (Fernandes et al., 1995). p27/kip is a cyclin dependent kinase inhibitor whose activity is deregulated in various kinds of cancer (Slingerland and Pagano, 2000; Bloom and Pagano, 2003). It has been proposed that CR inhibits induced mammary carcinogenesis by arresting cell cycle progression via up-regulation of the expression of p27/kip (Zhu et al., 1999). These observations further point towards the ability of CR to modulate the expression of oncogenes and tumor suppressor genes. Recently, epigenetic regulation by CR has been proposed as one of many mechanisms through which CR controls aging (Li et al., 2011). In fact, it has been shown that CR, by modulating epigenetic changes such as DNA methylation or histone modification, controls the expression of oncogenes and tumor suppressors (Hass et al., 1993; Li et al., 2010). The ability of CR to hyper-methylate the promoter of proto-oncogenes such as Ras, thus leading to their silencing, could contribute toward cancer prevention (Hass et al., 1993).
A recent study using WI-38 (normal cells) and SV-antigen transfected immortalized WI-38 cells (precancerous cells) showed that glucose restriction displayed an altered regulation of the expression of both hTERT and the tumor suppressor p16 in normal and precancerous cells. In normal cells, glucose restriction leads to increased expression of hTERT and decreased expression of p16, leading to delayed aging. However, in precancerous cells, glucose restriction leads to decreased expression of hTERT and increased expression of p16 leading to apoptosis (Li et al., 2010), suggesting that CR may mediate its anti-aging and anti-tumor activities via differential regulation of oncogenes and tumor suppressors by varied chromatin modifications. It can be also assumed that, through chromatin modulation, CR might bring out differential gene expression in normal and cancerous cells. Therefore, it would be interesting to examine the effect of CR on the gene expression profile of normal and cancerous cells.
Clinical Implications of Caloric Restriction
Although, reduction in calorie intake has emerged as a most potent broadly acting intervention that prevents cancer in experimental animals, its role at clinical level is yet to be defined. There are limited numbers of designed and controlled studies that are aimed to find out the efficacy of CR in humans. This is mainly because of the unavailability of human volunteers willing to follow a restricted diet regime despite CR claimed ability to provide a healthy prolonged life. However, epidemiological studies and observations from both natural and historical situations have indicated CR to be effective in humans too. Many of these analyses were carried out from the answers to questionnaires filled by human volunteers regarding their history, such as a study involving Spanish nursing residents indicating a beneficial effect of CR (Roth et al., 1999). Interestingly, studies utilizing data from cancer registries have shown a correlation between weight loss during adulthood and occurrence of breast cancer. Women's cohorts who experienced a weight loss in adulthood had reduced risk of developing breast cancer in comparison to the ones who gained weight (Trentham-Dietz et al., 2000; Harvie et al., 2005; Christou et al., 2008; Kawai et al., 2010). Likewise, a retrospective study in Swedish women who suffered from severe anorexia nervosa showed that they had a 53% lower incidence of breast cancer than the Swedish general population (Michels and Ekbom, 2004). Similarly, a decreased incidence of breast cancer was observed in Danish women suffering from anorexia nervosa, and in Norwegian pre-pubertal girls and Dutch women who had been exposed to famine during World War II (van Noord and Kaaks, 1991; Tretli and Gaard, 1996; Mellemkjær et al., 2001). Further, the women of the Okinawa community, who follow a traditional lower calorie diet, have lower incidence of breast cancer compared to other Japanese women (Willcox et al., 2007). These observations indicated that starvation or CR during adolescence and adulthood had clear impact on the development of breast cancer, as observed in the rodents. Most interestingly, the decreased prevalence of cancer and vascular diseases in the Okinawa community, due to less calorie intake habit, is considered to be responsible for their lower mortality rate and for their tumor free longer life (Kagawa, 1978). The questionnaire based study of the Netherlands Cohort, who experienced severe CR as adolescent during the Hunger Winter of World War II, has shown that energy restriction during childhood and adolescence also decreases the risk of colorectal and ovarian cancer (Dirx et al., 2003a,b; Hughes et al., 2009; Schouten et al., 2011). All these studies point toward a role for CR in the modulation of human cancer development.
Apart from these retrospective and historic observations, controlled studies involving cancer patients also indicated a promising effect of CR on cancer. A study involving the enrollment of obese persons in a weight loss program based on CR, showed a reduction in their rectal cell proliferation, a biomarker for colon carcinogenesis, suggesting that CR may prevent colon cancer (Steinbach et al., 1994). Another case report using a ketogenic diet that resulted in low blood glucose levels, as seen in caloric restricted animals, showed a decrease in tumor metabolism (Nebeling et al., 1995). These observations are encouraging and suggestive of the clinical potential of CR and merit further research.
Considering the robustness of the data regarding the beneficial effect of CR on a diverse range of ailments, further scrutiny of CR methods/application must be sought. As extensive CR is impractical to achieve in humans, studies directed at understanding the mechanism of action of CR are essential. These kinds of studies are required for the identification of effectors or pathways that could possibly be targeted to achieve the beneficial effect of CR. As discussed above, CR might exert its effect on various human ailments through different mechanisms. However, no direct evidence is available. Therefore, the mechanism of action of CR should not be assumed universal and needs to be examined in each disease condition.
The effect of CR on energy balance should not be ignored. There is growing evidence to suggest the association of energy balance including diet, weight, adiposity, and physical activity with tumorigenesis. It has been shown that increased energy expenditure due to increasing physical activities can reduce obesity and might be beneficial in delaying tumorigenesis, at least in some of the mouse models of mammary tumor (Cohen et al., 1988; Thompson et al., 1995; Thompson, 1997; Jakicic and Otto, 2005). However, as results on the tumor inhibiting ability of energy expenditure by exercise are controversial, a more extensive examination is required (Cohen et al., 1992; Gillette et al., 1997; Thompson et al., 1988). Additionally, a detailed and systematic quantitative analysis of the effect of energy intake, energy expenditure and energy balance on tumorigenesis and aging is warranted for the further scrutiny of this process.
One emerging alternative to CR is the use of CRMs. One of the known CRMs, Rapamycin has been shown to be effective in delaying aging as well as tumor growth, two main features of CR benefit. However, this field is still very undeveloped and requires more attention. Of course, novel CRMs might be discovered in the course of dissecting CR mechanisms.
Another unexplored area of research is the effect of CR on tumor suppressor and tumor promoter genes. Does CR exert its anti-tumorigenic effect through up-regulation of tumor suppressor genes or down-regulation of oncogenes? Interestingly, the p53 family of tumor suppressors has been shown to negatively regulate the Insulin-like Growth Factor 1 (IGF-1) Receptor (IGFR-1), an important player of the insulin receptor pathway, through which CR has been proposed to exert its action (Bruchim et al., 2009). Though, there is evidence that CR can increase apoptosis in tumor cells and can inhibit angiogenesis and invasive properties of cancer cells, its effect on other hallmarks of cancer is not explored (Mukherjee et al., 2002, 2004, 2008; Zhou et al., 2007; Shelton et al., 2010). Therefore, it would be also interesting to examine the ability of CR to target all the hallmarks of cancer (Figure 2).
Another very exciting and unexplored area is that of stem cell biology and CR. Although, a limited number of studies point toward the inhibitory effect of CR on progenitor stem cell proliferation, these need further validation (Yoshida et al., 1997). Finally, studies using human subjects are foremost important for the validation of CR efficacy. In all, we can say that CR is the only natural approach emerging as a conqueror against aging and cancer, and may pave our way toward a healthy prolonged life.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by the AIRC/Marie Curie incoming fellowship to Rani Pallavi. We thank Paola Dalton for editing the manuscript.
Baade, P. D., Youlden, D. R., and Krnjacki, L. J. (2009). International epidemiology of prostate cancer: geographical distribution and secular trends. Mol. Nutr. Food Res. 53, 171–184.
Beth, M., Berger, M. R., Aksoy, M., and Schmähl, D. (1987). Comparison between the effects of dietary fat level and of calorie intake on methylnitrosourea-induced mammary carcinogenesis in female SD rats. Int. J. Cancer 39, 737–744.
Berrigan, D., Perkins, S. N., Haines, D. C., and Hursting, S. D. (2002). Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23, 817–822.
Bloom, J., and Pagano, M. (2003). Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41–47.
Bruchim, I., Attias, Z., and Werner, H. (2009). Targeting the IGF1 axis in cancer proliferation. Expert Opin. Ther. Targets 13, 1179–1192.
Bunk, B., Zhu, P., Klinga, K., Berger, M. R., and Schmähl, D. (1992). Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br. J. Cancer 65, 845–851.
Calle, E. E., and Kaaks, R. (2004). Overweight, obesity and cancer: epidemiological evidenceand proposed mechanisms. Nat. Rev. Cancer 4, 579–591.
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. (1998). Plasma insulin-like growth factor–I and prostate cancer risk: a prospective study. Science 279, 563–566.
Christou, N. V., Lieberman, M., Sampalis, F., and Sampalis, J. S. (2008). Bariatric surgery reduces cancer risk in morbidly obese patients. Surg. Obes. Relat. Dis. 4, 691–695.
Clancy, D. J., Gems, D., Harshman, L. G., Oldham, S., Stocker, H., Hafen, E., Leevers, S. J., and Partridge, L. (2001). Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104–106.
Cohen, L. A., Boylan, E., Epstein, M., and Zang, E. (1992). Voluntary exercise and experimental mammary cancer. Adv. Exp. Med. Biol. 322, 41–59.
Cohen, L. A., Choi, K. W., and Wang, C. X. (1988). Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res. 48, 4276–4283.
Collaborative Group on Epidemiological Studies of Ovarian Cancer. (2012). Ovarian cancer and body size: individual participant meta-analysis including 25, 157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 9:e1001200. doi: 10.1371/journal.pmed.1001200
Coschigano, K. T., Clemmons, D., Bellush, L. L., and Kopchick, J. J. (2000). Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613.
Deyoung, M. P., Horak, P., Sofer, A., Sgroi, D., and Ellisen, L. W. (2008). Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling. Genes Dev. 22, 239–251.
Dirx, M. J., van den Brandt, P. A., Goldbohm, R. A., and Lumey, L. H. (2003a). Energy restriction early in life and colon carcinoma risk: results of the netherlands cohort study after 7.3 years of follow-up. Cancer 97, 46–55.
Dirx, M. J. M., Zeegers, M. P. A., Dagnelie, P. C., van den Bogaard, T., and van den Brandt, P. A. (2003b). Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int. J. Cancer 106, 766–770.
Dunn, S. E., Kari, F. W., French, J., Leininger, J. R., Travlos, G., Wilson, R., and Barrett, J. C. (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 57, 4667–4672.
Estep, P. W. 3rd., Warner, J. B., and Bulyk, M. L. (2009). Short-term calorie restriction in male mice feminizes gene expression and alters key regulators of conserved aging regulatory pathways. PLoS ONE 4:e5242. doi: 10.1371/journal.pone.0005242
Feldser, D. M., and Greider, C. W. (2007). Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11, 461–469.
Fernandes, G., Chandrasekar, B., Troyer, D. A., Venkatraman, J. T., and Good, R. A. (1995). Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92, 6494–6498.
Flurkey, K., Papaconstantinou, J., Miller, R. A., and Harrison, D. E. (2001). Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. U.S.A. 98, 6736–6741.
Fu, P. P., Dooley, K. L., Von Tungeln, L. S., Bucci, T., Hart, R. W., and Kadlubar, F. F. (1994). Caloric restriction profoundly inhibits liver tumor formation after initiation by 6-nitrochrysene in male mice. Carcinogenesis 15, 159–161.
Gems, D., and Partridge, L. (2001). Insulin/IGF-1 signalling and ageing: seeing the bigger picture. Curr. Opin. Genet. Dev. 11, 287–292.
Gillette, C. A., Zhu, Z., Westerlind, K. C., Melby, C. L., Wolfe, P., and Thompson, H. J. (1997). Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis 18, 1183–1188.
Goldstein, S. (1990). Replicative senescence: the human fibroblast comes of age. Science 249, 1129–1133.
Greer, E. L., and Brunet, A. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410–7425.
Greer, E. L., Banko, M. R., and Brunet, A. (2009). AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Ann. N.Y. Acad. Sci. 1170, 688–692.
Greer, E. L., Dowlatshahi, D., Banko, M. R., Villen, J., Hoang, K., Blanchard, D., Gygi, S. P., and Brunet, A. (2007). An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17, 1646–1656.
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. (1998). Circulating concentrations of insulin-like growth factor–I and risk of breast cancer. Lancet 351, 1393–1396.
Harvie, M., Howell, A., Vierkant, R. A., Kumar, N., Cerhan, J. R., Kelemen, L. E., Folsom, A. R., and Sellers, T. A. (2005). Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol. Biomarkers Prev. 14, 656–661.
Hass, B. S., Hart, R. W., Lu, M. H., and Lyn-Cook, B. D. (1993). Effects of caloric restriction in animals on cellular function, oncogene expression, and DNA methylation in vitro. Mutat. Res. 295, 281–289.
Hu, M. C., Lee, D. F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J. Y., Zou, Y., Bao, S., Hanada, N., Saso, H., Kobayashi, R., and Hung, M. C. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225–237.
Hughes, L. A., van den Brandt, P. A., de Bruïne, A. P., Wouters, K. A., Hulsmans, S., Spiertz, A., Goldbohm, R. A., de Goeij, A. F., Herman, J. G., Weijenberg, M. P., and van Engeland, M. (2009). Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS ONE 4:e7951. doi: 10.1371/journal.pone.0007951
Hursting, S. D., Perkins, S. N., Brown, C. C., Haines, D. C., and Phang, J. M. (1997). Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res. 57, 2843–2846.
Hursting, S. D., Perkins, S. N., and Phang, J. M. (1994). Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91, 7036–7040.
Hursting, S. D., Perkins, S. N., Phang, J. M., and Barrett, J. C. (2001). Diet and cancer prevention studies in p53-deficient mice. J. Nutr. 131, 3092S–3094S.
Hursting, S. D., Slaga, T. J., Fischer, S. M., Di Giovanni, J., and Phang, J. M. (1999). Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. 91, 215–225.
Hursting, S. D., Switzer, B. R., French, J. E., and Kari, F. W. (1993). The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction–induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res. 53, 2750–2757.
Isaksson, O. G., Lindahl, A., Nilsson, A., and Isgaard, J. (1987). Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr. Rev. 8, 426–438.
Jakicic, J. M., and Otto, A. D. (2005). Physical activity considerations for the treatment and prevention of obesity. Am. J. Clin. Nutr. 82, 226S–229S.
Kagawa, Y. (1978). Impact of Westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev. Med. 7, 205–217.
Kalaany, N. Y., and Sabatini, D. M. (2009). Tumours with PI3K activation are resistant to dietaryrestriction. Nature 458, 725–731.
Kawai, M., Minami, Y., Kuriyama, S., Kakizaki, M., Kakugawa, Y., Nishino, Y., Ishida, T., Fukao, A., Tsuji, I., and Ohuchi, N. (2010). Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the miyagi cohort study. Br. J. Cancer 103, 1443–1447.
Kenyon, C. (2005). The plasticity of aging: insights from long-lived mutants. Cell 120, 449–460.
Kharazi, A. I., James, S. J., Taylor, J. M., Lubinski, J. M., Nakamura, L. T., and Makinodan, T. (1994). Combined chronic low dose radiation-caloric restriction: a model for regression of spontaneous mammary tumor. Int. J. Radiat. Oncol. Biol. Phys. 28, 641–647.
Kim, H. S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S. H., Singh, K. K., Abdulkadir, S. A., Spitz, D. R., Deng, C. X., and Gius, D. (2010). SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 41–52.
Kolonel, L. N., Altshuler, D., and Henderson, B. E. (2004). The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat. Rev. Cancer 4, 519–527.
Kumar, S. P., Roy, S. J., Tokumo, K., and Reddy, B. S. (1990). Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res. 50, 5761–5766.
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., McTiernan, A., Gansler, T., Andrews, K. S., Thun, M. J., and American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. (2006). American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 56, 254–281.
Lashinger, L. M., Malone, L. M., McArthur, M. J., Goldberg, J. A., Daniels, E. A., Pavone, A., Colby, J. K., Smith, N. C., Perkins, S. N., Fischer, S. M., and Hursting, S. D. (2011). Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia. Cancer Prev. Res. (Phila.) 4, 1030–1040.
LeRoith, D., Baserga, R., Helman, L., and Roberts, C. T. Jr. (1995). Insulin-like growth factors and cancer. Ann. Intern. Med. 122, 54–59.
Li, H. W., Zhao, W., and Sarkar, N. H. (1994). Dietary regulation of mammary tumorigenesis in RIII/Sa mice: investigation of a possible mechanism. Cancer Lett. 79, 199–211.
Li, Y., Daniel, M., and Tollefsbol, T. O. (2011). Epigenetic regulation of caloric restriction in aging. BMC Med. 9, 98.
Li, Y., Liu, L., and Tollefsbol, T. O. (2010). Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J. 24, 1442–1453.
Lin, K., Dorman, J. B., Rodan, A., and Kenyon, C. (1997). daf-16, An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319–1322.
Lin, K., Hsin, H., Libina, N., and Kenyon, C. (2001). Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28, 139–145.
Lleonart, M. E., Artero-Castro, A., and Kondoh, H. (2009). Senescence induction; a possible cancer therapy. Mol. Cancer 8, 3.
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)–I and IGF–binding protein–3. J. Natl. Cancer Inst. 91, 620–625.
Macaulay, V. M. (1992). Insulin-like growth factors and cancer. Br. J. Cancer 65, 311–320.
Mai, V., Colbert, L. H., Berrigan, D., Perkins, S. N., Pfeiffer, R., Lavigne, J. A., Lanza, E., Haines, D. C., Schatzkin, A., and Hursting, S. D. (2003). Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res. 63, 1752–1755.
Mccay, C. M., Ellis, G. H., Barnes, L. L., Smith, C. A. H., and Sperling, G. (1939). Chemical and pathological changes in aging and after retarded growth. J. Nutr. 18, 15–25.
Mei, J. J., Hursting, S. D., Perkins, S. N., and Phang, J. M. (1998). p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Lett. 129, 191–197.
Mellemkjær, L., Emborg, C., Gridley, G., Munk-JØrgensen, P., Johansen, C., TjØnneland, A., Kjaer, S. K., and Olsen, J. H. (2001). Anorexia nervosa and cancer risk. Cancer Causes Control 12, 173–177.
Michels, K. B., and Ekbom, A. (2004). Caloric restriction (CR) and incidence of breast cancer. JAMA 291, 1226–1230.
Mukherjee, P., Abate, L. E., and Seyfried, T. N. (2004). Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin. Cancer Res. 10, 5622–5656.
Mukherjee, P., El-Abbadi, M. M., Kasperzyk, J. L., Ranes, M. K., and Seyfried, T. N. (2002). Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br. J. Cancer 86, 1615–1621.
Mukherjee, P., Mulrooney, T. J., Marsh, J., Blair, D., Chiles, T. C., and Seyfried, T. N. (2008). Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol. Cancer 7, 37.
Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J. R., Visek, W. J., and Clinton, S. K. (1999). Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J. Natl. Cancer. Inst. 91, 512–523.
Naqvi, A., Hoffman, T. A., DeRicco, J., Kumar, A., Kim, C. S., Jung, S. B., Yamamori, T., Kim, Y. R., Mehdi, F., Kumar, S., Rankinen, T., Ravussin, E., and Irani, K. (2010). A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Hum. Mol. Genet. 19, 4123–4133.
Nebeling, L. C., Miraldi, F., Shurin, S. B., and Lerner, E. (1995). Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J. Am. Coll. Nutr. 14, 202–208.
Nogueira, L. M., Dunlap, S. M., Ford, N. A., and Hursting, S. D. (2012). Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity. Endocr. Relat. Cancer 19, 57–68.
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., and Ruvkun, G. (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999.
Oliveras-Ferraros, C., Vazquez-Martin, A., and Menendez, J. A. (2010). Pharmacological mimicking of caloric restriction elicits epigenetic reprogramming of differentiated cells to stem-like self-renewal states. Rejuvenation Res. 13, 519–526.
Pelicano, H., Carney, D., and Huang, P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7, 97–110.
Phoenix, K. N., Vumbaca, F., Fox, M. M., Evans, R., and Claffey, K. P. (2010). Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res. Treat. 123, 333–344.
Pili, R., Guo, Y., Chang, J., Nakanishi, H., Martin, G. R., and Passaniti, A. (1994). Altered angiogenesis underlying age-dependent changes in tumor growth. J. Natl. Cancer Inst. 86, 1303–1314.
Probst-Hensch, N. M., Pike, M. C., McKean-Cowdin, R., Stanczyk, F. Z., Kolonel, L. N., and Henderson, B. E. (2000). Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br. J. Cancer 82, 1867–1870.
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., and Chen, D. (2010). Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662–667.
Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L., and Sellers, W. R. (2002). A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2, 81–91.
Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. (1995). The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55, 2463–2469.
Roebuck, B. D., Baumgartner, K. J., and MacMillan, D. L. (1993). Caloric restriction and intervention in pancreatic carcinogenesis in the rat. Cancer Res. 53, 46–52.
Roth, G. S., Ingram, D. K., and Lane, M. A. (1999). Calorie restriction in primates: will it work and how will we know? J. Am. Geriatr. Soc. 47, 896–903.
Ruggeri, B. A., Klurfeld, D. M., Kritchevsky, D., and Furlanetto, R. W. (1989). Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res. 49, 4130–4134.
Schaefer, C., Friedman, G. D., Quesenberry, C. P. Jr., Orentreich, N., and Vogelman, J. H. (1998). IGF-1 and prostate cancer. Science 282, 199a.
Schouten, L. J., van Dijk, B. A., Lumey, L. H., Goldbohm, R. A., and van den Brandt, P. A. (2011). Energy restriction during childhood and early adulthood and ovarian cancer risk. PLoS ONE 6:e27960. doi: 10.1371/journal.pone.0027960
Sell, Ch. (2003). Caloric restriction and insulin-like growth factors in aging and cancer. Horm. Metab. Res. 35, 705–711.
Shelton, L. M., Huysentruyt, L. C., Mukherjee, P., and Seyfried, T. N. (2010). Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN Neuro 2, e00038.
Singh, P., Dai, B., Yallampalli, U., Lu, X., and Schroy, P. C. (1996). Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein–4, role of IGF-II. Endocrinology 137, 1764–1774.
Slingerland, J., and Pagano, M. (2000). Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183, 10–17.
Steinbach, G., Heymsfield, S., Olansen, N. E., Tighe, A., and Holt, P. R. (1994). Effect of caloric restriction on colonic proliferation in obese persons: implications for colon cancer prevention. Cancer Res. 54, 1194–1197.
Tannenbaum, A. (1940). Relationship of body weight to cancer incidence. Arch. Path. 30, 509–517.
Tannenbaum, A. (1942). The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res. 2, 460–467.
Tatar, M., Kopelman, A., Epstein, D., Tu, M. P., Yin, C. M., and Garofalo, R. S. (2001). A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110.
Thompson, H. J. (1997). Effects of physical activity and exercise on experimentally-induced mammary carcinogenesis. Breast Cancer Res. Treat. 46, 135–141.
Thompson, H. J., Ronan, A. M., Ritacco, K. A., Tagliaferro, A. R., and Meeker, L. D. (1988). Effect of exercise on the induction of mammary carcinogenesis. Cancer Res. 48, 2720–2723.
Thompson, H. J., Westerlind, K. C., Snedden, J., Briggs, S., and Singh, M. (1995). Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 16, 1783–1786.
Trentham-Dietz, A., Newcomb, P. A., Egan, K. M., Titus-Ernstoff, L., Baron, J. A., Storer, B. E., Stampfer, M., and Willett, W. C. (2000). Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11, 533–542.
Tretli, S., and Gaard, M. (1996). Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of World War II in Norway. Cancer Causes Control 7, 507.
van Noord, P. A., and Kaaks, R. (1991). The effect of wartime conditions and the 1944–45 “Dutch famine” on recalled menarcheal age in participants of the DOM breast cancer screening project. Ann. Hum. Biol. 18, 57–70.
Wang, C., Maddick, M., Miwa, S., Jurk, D., Czapiewski, R., Saretzki, G., Langie, S. A., Godschalk, R. W., Cameron, K., and von Zglinicki, T. (2010). Adult-onset, short-term dietary restriction reduces cell senescence in mice. Aging (Albany NY) 2, 555–566.
Wei, C. L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Liu, J., Zhao, X. D., Chew, J. L., Lee, Y. L., Kuznetsov, V. A., Sung, W. K., Miller, L. D., Lim, B., Liu, E. T., Yu, Q., Ng, H. H., and Ruan, Y. (2006). A global map of p53 transcription-factor binding sites in the human genome. Cell 124, 207–219.
Weindruch, R., and Walford, R. L. (1988). The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas.
Willcox, B. J., Willcox, D. C., Todoriki, H., Fujiyoshi, A., Yano, K., He, Q., Curb, J. D., and Suzuki, M. (2007). Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann. N.Y. Acad. Sci. 1114, 434–455.
Wolk, A., Mantzoros, C. S., Andersson, S. O., Bergström, R., Signorello, L. B., Lagiou, P., Adami, H. O., and Trichopoulos, D. (1998). Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl. Cancer Inst. 90, 911–915.
Yamaza, H., Komatsu, T., Wakita, S., Kijogi, C., Park, S., Hayashi, H., Chiba, T., Mori, R., Furuyama, T., Mori, N., and Shimokawa, I. (2010). FoxO1 is involved in the antineoplastic effect of calorie restriction. Aging Cell 9, 372–382.
Yang, H., Zhao, R., Yang, H. Y., and Lee, M. H. (2005). Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene 24, 1924–1935.
Yoshida, K., Hirabayashi, Y., Watanabe, F., Sado, T., and Inoue, T. (2006). Caloric restriction prevents radiation-induced myeloid leukemia in C3H/HeMs mice and inversely increases incidence of tumor-free death: implications in changes in number of hemopoietic progenitor cells. Exp. Hematol. 34, 274–283.
Yoshida, K., Inoue, T., Hirabayashi, Y., Matsumura, T., Nemoto, K., and Sado, T. (1997). Radiation-induced myeloid leukemia in mice under calorie restriction. Leukemia 3, 410–412.
Yoshida, K., Inoue, T., Hirabayashi, Y., Nojima, K., and Sado, T. (1999). Calorie restriction and spontaneous hepatic tumors in C3H/He mice. J. Nutr. Health Aging 3, 121–126.
Youngman, L. D., Park, J. Y., and Ames, B. N. (1992). Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc. Natl. Acad. Sci. U.S.A. 89, 9112–9116.
Yu, H., and Rohan, T. (2000). Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92, 1472–1489.
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., and Wu, X. (1999). Plasma levels of insulin-like growth factor–I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91, 151–156.
Zhou, W., Mukherjee, P., Kiebish, M. A., Markis, W. T., Mantis, J. G., and Seyfried, T. N. (2007). The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr. Metab. (Lond.) 4, 5.
Zhu, Z., Jiang, W., and Thompson, H. J. (1999). Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol. Carcinog. 24, 241–245.
Keywords: caloric restriction, dietary restriction, cancer, anti-tumor effect, aging
Citation: Pallavi R, Giorgio M and Pelicci PG (2012) Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life. Front. Physio. 3:318. doi: 10.3389/fphys.2012.00318
Received: 15 April 2012; Paper pending published: 18 May 2012;
Accepted: 19 July 2012; Published online: 09 August 2012.
Edited by:Vladimir Titorenko, Concordia University, Canada
Reviewed by:François Haman, University of Ottawa, Canada
Vladimir Titorenko, Concordia University, Canada
Copyright © 2012 Pallavi, Giorgio and Pelicci. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Rani Pallavi and Pier G. Pelicci, European Institute of Oncology, IFOM-IEO Campus, Via Adamello, 16, 20139 Milan, Italy. e-mail: email@example.com; firstname.lastname@example.org